↓ Skip to main content

Dove Medical Press

Ocular surface squamous neoplasia in HIV-infected patients: current perspectives

Overview of attention for article published in HIV/AIDS (Auckland, N.Z.), March 2018
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
54 Mendeley
Title
Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
Published in
HIV/AIDS (Auckland, N.Z.), March 2018
DOI 10.2147/hiv.s120517
Pubmed ID
Authors

Shweta Gupta Rathi, Anasua Ganguly Kapoor, Swathi Kaliki

Abstract

Ocular surface squamous neoplasia (OSSN) refers to a spectrum of conjunctival and corneal epithelial tumors including dysplasia, carcinoma in situ, and invasive carcinoma. In this article, we discuss the current perspectives of OSSN associated with HIV infection, focusing mainly on the epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of these tumors in patients with HIV. Upsurge in the incidence of OSSN with the HIV pandemic most severely affected sub-Saharan Africa, due to associated risk factors, such as human papilloma virus and solar ultraviolet exposure. OSSN has been reported as the first presenting sign of HIV/AIDS in 26%-86% cases, and seropositivity is noted in 38%-92% OSSN patients. Mean age at presentation of OSSN has dropped to the third to fourth decade in HIV-positive patients in developing countries. HIV-infected patients reveal large aggressive tumors, higher-grade malignancy, higher incidence of corneal, scleral, and orbital invasion, advanced-stage T4 tumors, higher need for extended enucleation/exenteration, and increased risk of tumor recurrence. Current management of OSSN in HIV-positive individuals is based on standard treatment guidelines described for OSSN in the general population, as there is little information available about various treatment modalities or their outcomes in patients with HIV. OSSN can occur at any time in the disease course of HIV/AIDS, and no significant trend has been discovered between CD4 count and grade of OSSN. Furthermore, the effect of highly active antiretroviral therapy on OSSN is controversial. The current recommendation is to conduct HIV screening in all cases presenting with OSSN to rule out undiagnosed HIV infection. Patient counseling is crucial, with emphasis on regular follow-up to address high recurrence rates and early presentation to an ophthalmologist for of any symptoms in the unaffected eye. Effective evidence-based interventions are needed to allow early diagnosis and treatment, as well as prevention of the disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 11%
Lecturer 5 9%
Student > Postgraduate 4 7%
Student > Bachelor 4 7%
Student > Ph. D. Student 3 6%
Other 9 17%
Unknown 23 43%
Readers by discipline Count As %
Medicine and Dentistry 17 31%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 3 6%
Social Sciences 2 4%
Immunology and Microbiology 2 4%
Other 4 7%
Unknown 23 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2018.
All research outputs
#20,064,197
of 25,523,622 outputs
Outputs from HIV/AIDS (Auckland, N.Z.)
#230
of 331 outputs
Outputs of similar age
#254,218
of 345,226 outputs
Outputs of similar age from HIV/AIDS (Auckland, N.Z.)
#4
of 5 outputs
Altmetric has tracked 25,523,622 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 331 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,226 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one.